REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-20: Form 6-K; Period of report 2023-12-20; Description 6-K; Document zk2330676.htm.
- 2023-12-12: Form 6-K; Period of report 2023-12-12; Description 6-K; Document zk2330646.htm.
- 2023-12-06: Form 6-K; Period of report 2023-12-06; Description 6-K; Document zk2330637.htm.
- 2023-12-04: Form 6-K; Period of report 2023-12-04; Description 6-K; Document zk2330626.htm.